Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway

被引:286
|
作者
Miao, H
Wei, BR
Peehl, DM
Li, Q
Alexandrou, T
Schelling, JR
Rhim, JS
Sedor, JR
Burnett, E
Wang, BC
机构
[1] Case Western Reserve Univ, Sch Med, Rammelkamp Ctr Res, Cleveland, OH 44109 USA
[2] Case Western Reserve Univ, Sch Med, Ireland Canc Ctr, Cleveland, OH 44109 USA
[3] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44109 USA
[4] Stanford Univ, Dept Urol, Stanford, CA 94305 USA
[5] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/35074604
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interactions between Eph receptor tyrosine kinases (RTKs) and membrane-anchored ephrin ligands critically regulate axon pathfinding and development of the cardiovascular system, as well as migration of neural cells. Similar to other RTKs, ligand-activated Eph kinases recruit multiple signalling and adaptor proteins, several of which are involved in growth regulation(1,2). However, in contrast to other RTKs, activation of Eph receptors fails to promote cell proliferation(3,4) or to transform rodent fibroblasts(5), indicating that Eph kinases may initiate signalling pathways that are distinct from those transmitted by other RTKs. Here we show that stimulation of endogenous EphA kinases with ephrin-A1 potently inhibits the Ras/MAPK cascade in a range of cell types, and attenuates activation of mitogen-activated protein kinase (MAPK) by receptors for platelet-derived growth factor (PDGF), epidermal growth factor (EGF) and Vascular endothelial growth factor (VEGF). In prostatic epithelial cells and endothelial cells, but not fibroblasts, treatment with ephrin-A1 inhibits cell proliferation. Our results identify EphA kinases as negative regulators of the Ras/MAPK pathway that exert anti-mitogenic functions in a cell-type-specific manner.
引用
收藏
页码:527 / 530
页数:4
相关论文
共 50 条
  • [1] Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway
    Hui Miao
    Bih-Rong Wei
    Donna M. Peehl
    Qing Li
    Terry Alexandrou
    Jeffrey R. Schelling
    Johng S. Rhim
    John R. Sedor
    Elisabeth Burnett
    Bingcheng Wang
    Nature Cell Biology, 2001, 3 : 527 - 530
  • [2] A Conditional Transmembrane Peptide Inhibits Cell Migration by Activation of the EphA2 Receptor Tyrosine Kinase
    Alves, Daiane S.
    Westerfield, Justin M.
    Shi, Xiaojun
    Nguyen, Vanessa P.
    Stefanski, Katherine M.
    Smith, Adam W.
    Barrera, Francisco N.
    BIOPHYSICAL JOURNAL, 2019, 116 (03) : 176A - 176A
  • [3] A Novel Membrane Peptide that Inhibits Cell Migration by Activation of the Receptor Tyrosine Kinase EphA2
    Westerfield, Justin M.
    Alves, Daiane S.
    Shi, Xiaojun
    Nguyen, Vanessa P.
    Pullen, Robert H., III
    Stefanski, Katherine M.
    Booth, Kristen
    Morrell-Falvey, Jennifer
    Wang, Bing-Cheng
    Abel, Steven M.
    Smith, Adam W.
    Barrera, Francisco N.
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 265A - 265A
  • [4] Activation of the EphA2 receptor tyrosine kinase by a conditional transmembrane peptide
    Barrera, Francisco
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [5] Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis
    Cheng, N
    Brantley, DM
    Liu, H
    Lin, O
    Enriquez, M
    Gale, N
    Yancopoulos, G
    Cerretti, DP
    Daniel, TO
    Chen, J
    MOLECULAR CANCER RESEARCH, 2002, 1 (01) : 2 - 11
  • [6] Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway
    Orton, RJ
    Sturm, OE
    Vyshemirsky, V
    Calder, M
    Gilbert, DR
    Kolch, W
    BIOCHEMICAL JOURNAL, 2005, 392 : 249 - 261
  • [7] Dimerization of the EphA1 Receptor Tyrosine Kinase Transmembrane Domain: Insights into the Mechanism of Receptor Activation
    Chavent, Matthieu
    Chetwynd, Alan P.
    Stansfeld, Phillip J.
    Sansom, Mark S. P.
    BIOCHEMISTRY, 2014, 53 (42) : 6641 - 6652
  • [8] Receptor Tyrosine Kinase-RAS Pathway Mutation Is Enriched in Myeloid Sarcoma
    Choi, Mihong
    Jeon, Yoon Kyung
    Sun, Choong-Hyun
    Yun, Hong-Seok
    Lee, Hyun Jung
    Hong, Junshik
    Shin, Dong-Yeop
    Kim, Inho
    Yoon, Sung-Soo
    Koh, Youngil
    BLOOD, 2017, 130
  • [9] ACTIVATION OF RAS BY RECEPTOR TYROSINE KINASES
    MARGOLIS, B
    SKOLNIK, EY
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (06): : 1288 - 1299
  • [10] Functional Oligomerization of the EphA2 Receptor Tyrosine Kinase
    Shi, Xiaojun
    Lingrak, Ryan
    Cuizon, Carmelle
    Toth, Paul
    Zheng, Ji
    Smith, Adam
    Wang, Bingcheng
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 97A - 97A